Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Mitchell | Genex | Coventry agrees to acquire QualCare
Deal will strengthen company's network in New Jersey San Diego, CA — May 11, 2021 — Mitchell | Ge
Workers' Comp
Podcast
Quality Assurance in Case Management
Workers' Comp
Article
Self-service tools can bring savings for both payers and providers
The phone in your pocket shouldn’t really be called a phone, should it? After all, making calls isn’t its primary purpose.
Mitchell
News Release
Mitchell Teams With Mazda North American Operations to Launch U.S. Collision Repair Network
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Workers' Comp
News Release
Workerscompensation.com: Sikorsky Sees 'Dramatic Results' with Onsite RTW Program
Sarasota, FL (Workerscompensation.com) – Sikorsky, a Lockheed Martin Company, saw a 48 percent reduction in lost workdays within 9 months o
Workers' Comp
Virtual Event
Webinar: Onsite Return to Work: A Sikorsky Approach
On-Demand
Since Lockheed Martin (LMC) acquired Sikorsky, medical treatment return-to-work (RTW) protocols have been developed in collaboration with Sik